CN112480254B - 抗人白细胞介素-33受体的抗体及其制备方法和应用 - Google Patents
抗人白细胞介素-33受体的抗体及其制备方法和应用 Download PDFInfo
- Publication number
- CN112480254B CN112480254B CN201910868040.0A CN201910868040A CN112480254B CN 112480254 B CN112480254 B CN 112480254B CN 201910868040 A CN201910868040 A CN 201910868040A CN 112480254 B CN112480254 B CN 112480254B
- Authority
- CN
- China
- Prior art keywords
- antibody
- amino acid
- seq
- antigen
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Abstract
Description
抗体编号 | EC50(ng/ml) |
2 | 19.5 |
8 | 22.9 |
11 | 23.7 |
17 | 28.4 |
21 | 25.4 |
31 | 27.6 |
35 | 33.7 |
47 | 28.1 |
49 | 27.9 |
51 | 26.0 |
53 | 22.5 |
54 | 17.3 |
65 | 22.1 |
67 | 31.1 |
78 | 18.7 |
82 | 21.2 |
93 | 25.5 |
98 | 21.4 |
118 | 26.0 |
122 | 24.6 |
抗体编号 | IC50(ng/ml) |
2 | 210.0 |
8 | 242.9 |
11 | 183.0 |
17 | 175.0 |
21 | 173.0 |
31 | 234.7 |
35 | 108.8 |
47 | 195.3 |
49 | 141.4 |
51 | 235.6 |
53 | 345.9 |
54 | 241.8 |
65 | 325.0 |
67 | 279.5 |
78 | 200.9 |
82 | 237.0 |
93 | 175.3 |
98 | 216.6 |
118 | 238.0 |
122 | 138.8 |
抗体 | IC50(ng/ml) |
RG6149 | 403.1 |
35H | 310.7 |
53H | 216.1 |
54H | 71.3 |
82H | 271.3 |
抗体 | IC50(ng/ml) |
RG6149 | 220.4 |
35H | 106.5 |
53H | 44.8 |
54H | 18.1 |
82H | 180.3 |
抗体 | Ka(1/Ms) | Kd(1/s) | KD(pM) |
RG6149 | 5.679x 105 | 8.198x 10-5 | 144.4 |
35H | 1.247x 106 | 1.386x 10-4 | 111.1 |
53H | 1.906x 106 | 1.392x 10-4 | 73.0 |
54H | 5.001x 106 | 1.013x 10-4 | 20.3 |
82H | 1.019x 106 | 5.015x 10-5 | 49.2 |
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910868040.0A CN112480254B (zh) | 2019-09-12 | 2019-09-12 | 抗人白细胞介素-33受体的抗体及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910868040.0A CN112480254B (zh) | 2019-09-12 | 2019-09-12 | 抗人白细胞介素-33受体的抗体及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112480254A CN112480254A (zh) | 2021-03-12 |
CN112480254B true CN112480254B (zh) | 2023-06-06 |
Family
ID=74920661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910868040.0A Active CN112480254B (zh) | 2019-09-12 | 2019-09-12 | 抗人白细胞介素-33受体的抗体及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112480254B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113493513B (zh) * | 2021-06-30 | 2022-07-12 | 深圳大学 | 抗人il-33中和性自身抗体及其制备方法和应用 |
CN115947855B (zh) * | 2022-05-20 | 2023-10-27 | 杭州邦顺制药有限公司 | 抗cd24抗体的制备及其用途 |
CN117024595B (zh) * | 2023-10-08 | 2024-01-26 | 江西乐成欣生生物技术研究有限责任公司 | 抗人st2的单克隆抗体及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102003075B1 (ko) * | 2011-02-23 | 2019-07-23 | 에프. 호프만-라 로슈 아게 | 인간 il33r에 대한 항체 및 이의 용도 |
FR2972006B1 (fr) * | 2011-02-24 | 2016-03-25 | Centre Nat Rech Scient | Nouveaux fragments d'il-33 superactifs et leurs utilisations |
-
2019
- 2019-09-12 CN CN201910868040.0A patent/CN112480254B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN112480254A (zh) | 2021-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111171150B (zh) | 抗人tslp抗体及其用途 | |
US20200325236A1 (en) | Agonistic 4-1bb monoclonal antibody | |
US11525005B2 (en) | Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof | |
US20220340654A1 (en) | Antibody capable of binding to thymic stromal lymphopoietin and use thereof | |
CN112480254B (zh) | 抗人白细胞介素-33受体的抗体及其制备方法和应用 | |
US20210238294A1 (en) | Human il-4r binding antibody, antigen binding fragment thereof, and medical use thereof | |
CN112041347B (zh) | 结合人il-4r的抗体、其制备方法和用途 | |
US20230088269A1 (en) | Anti-il-22r antibodies | |
WO2021208881A1 (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
US20200369774A1 (en) | Il-6r antibody and antigen binding fragment thereof and medical use | |
CN114286827B (zh) | 人源化抗il17a抗体及其应用 | |
CN112480252B (zh) | 抗白细胞介素-33抗体及其制备方法和应用 | |
EP4242229A1 (en) | Antibody against human thymic stromal lymphopoietin, preparation method therefor and application thereof | |
KR102598319B1 (ko) | 항-il-25 항체 및 그의 용도 | |
RU2807060C1 (ru) | Антитело к альфа-рецептору интерлейкина-4 человека, способ его получения и его применение | |
WO2021218574A1 (zh) | 结合人ngf的抗体、其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Chenghai Inventor after: Guo Jinlin Inventor after: Dang Wei Inventor after: Wu Yipan Inventor after: Yuan Yujing Inventor after: Zou Qiuling Inventor after: Li Zhike Inventor after: Wang Yang Inventor before: Zhang Chenghai Inventor before: Zhu Lingqiao Inventor before: Guo Jinlin Inventor before: Dang Wei Inventor before: Wu Yipan Inventor before: Yuan Yujing Inventor before: Zou Qiuling Inventor before: Li Zhike Inventor before: Wang Yang Inventor before: Li Wuping |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |